Performance Comparison of Oximetry Devices During 6-Minute Walk Tests
<b>Background:</b> Pulse oximetry is a common technique used to measure S<sub>pO<sub>2</sub></sub>, with increasing numbers of portable devices of different designs and technical specifications. This study examined accuracy of commercial and medical-grade portable oximetry devices (BioBeat wristwatch, Nonin WristOx<sub>2</sub> 3150, and Heart Sure A320) in measuring S<sub>pO<sub>2</sub></sub> compared with the reference standard (Masimo Rad-5) during 6-min walk tests (6MWTs). <b>Methods:</b> This prospective study included 50 subjects, with 10 recruited for each of the five target groups, including COPD, interstitial lung disease, pulmonary hypertension, oxygen therapy users, and other cardiac/respiratory diseases. All subjects underwent 6MWT using the reference standard and the three test oximetry devices. Accuracy was measured by comparing mean nadir S<sub>pO<sub>2</sub></sub>. Subjects were asked to rate their preference for different oximetry devices at test completion. <b>Results:</b> In contrast to the Masimo, the Nonin had lower nadir and mean S<sub>pO<sub>2</sub></sub> <i>(P</i> ≤ .001 for both), with higher measurements for the BioBeat (<i>P</i> < .001 for both) and no differences for the Heart Sure (<i>P</i> = .18 for nadir S<sub>pO<sub>2</sub></sub>, <i>P</i> <b>=</b> .96 for mean S<sub>pO<sub>2</sub></sub>). Time spent at S<sub>pO<sub>2</sub></sub> ≤ 88 was higher for the Nonin (70%, <i>P</i> < .001) but lower for the Heart Sure (58%, <i>P</i> < .001), compared with the Masimo (64%). There were no significant differences observed in peak heart rate measurements between the Masimo with the Nonin and BioBeat (<i>P</i> < .05 for both), with lower measurements using the Heart Sure (<i>P</i> < .001). The BioBeat was most preferable amongst subjects (<i>n =</i> 31), with all test oximeters having high patient satisfaction (mean \7-point Likert scale scores of 6-7). <b>Conclusion:</b> The Heart Sure A320 and Nonin Wrist-Ox<sub>2</sub> 3150 had comparable performance in detecting nadir S<sub>pO<sub>2</sub></sub> within a mean difference of 3% in comparison with the Masimo Rad-5, with potential use for remote monitoring.
Authors
- M. Horrigan
- T Churchward (ORCID: https://orcid.org/0000-0003-1471-9318)
- Karla Logie (ORCID: https://orcid.org/0000-0001-7671-098X)
- Max Schulte
- Leona Dowman (ORCID: https://orcid.org/0000-0001-8122-8063)
- Julian Gin (ORCID: https://orcid.org/0000-0002-5365-2008)
- Yet Hong Khor (ORCID: https://orcid.org/0000-0002-5434-9342)
- E. Marshall
- Angeline Filiex
Institutions
- The University of Melbourne (AU)
- Monash Alfred Psychiatry Research centre (AU)
- Institute for Breathing and Sleep (AU)
- Respiratory Clinical Trials (AU)
- Austin Health (AU)
Publication Details
- Journal
- Respiratory Care
- Published
- 2025-04-12
- DOI
- https://doi.org/10.1089/respcare.12259
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00